120 related articles for article (PubMed ID: 12756809)
21. [Humoral response to selected antigens of Yersinia enterocolitica and Yersinia pseudotuberculosis in the course of yersiniosis in humans. I. Occurrence of antibodies to Yersinia lipopolisacharydes and Yop proteins by ELISA].
Rastawicki W
Med Dosw Mikrobiol; 2006; 58(4):303-19. PubMed ID: 17642308
[TBL] [Abstract][Full Text] [Related]
22. Impact of the Yersinia pseudotuberculosis-derived mitogen (YPM) on the murine immune system.
Carnoy C; Loiez C; Faveeuw C; Grangette C; Desreumaux P; Simonet M
Adv Exp Med Biol; 2003; 529():133-5. PubMed ID: 12756744
[No Abstract] [Full Text] [Related]
23. Critical role of T cell migration in bacterial superantigen-mediated shock in mice.
Kano H; Ito Y; Matsuoka K; Nakajima T; Iwata T; Kohsaka T; Saito H; Abe J
Clin Immunol; 2004 Feb; 110(2):159-71. PubMed ID: 15003813
[TBL] [Abstract][Full Text] [Related]
24. Seroepidemiologic study on the occurrence of antibodies against Yersinia enterocolitica and Yersinia pseudotuberculosis in urban and rural population of the Lublin region (eastern Poland).
Stojek NM
Ann Agric Environ Med; 1999; 6(1):57-61. PubMed ID: 10384217
[TBL] [Abstract][Full Text] [Related]
25. Trypsin-like proteinase and its endogenous inhibitor from Yersinia pseudotuberculosis. Biological activity.
Burtseva TI; Loenko YN
Biochemistry (Mosc); 1999 Sep; 64(9):986-9. PubMed ID: 10521713
[TBL] [Abstract][Full Text] [Related]
26. A novel superantigenic exotoxin from Yersinia psuedotuberculosis and its position in the classification of the entire bacterial toxins.
Uchiyama T
Contrib Microbiol Immunol; 1995; 13():191-4. PubMed ID: 8833831
[No Abstract] [Full Text] [Related]
27. Yersinia pseudotuberculosis anti-inflammatory components reduce trinitrobenzene sulfonic acid-induced colitis in the mouse.
Marceau M; Dubuquoy L; Caucheteux-Rousseaux C; Foligne B; Desreumaux P; Simonet M
Infect Immun; 2004 Apr; 72(4):2438-41. PubMed ID: 15039377
[TBL] [Abstract][Full Text] [Related]
28. Analysis of Kawasaki disease showing elevated antibody titres of Yersinia pseudotuberculosis.
Tahara M; Baba K; Waki K; Arakaki Y
Acta Paediatr; 2006 Dec; 95(12):1661-4. PubMed ID: 17129979
[TBL] [Abstract][Full Text] [Related]
29. Attenuation and preserved immunogenic potential of Yersinia pseudotuberculosis mutant strains evidenced in oral pig model.
Najdenski H; Golkocheva-Markova E; Kussovski V; Vesselinova A; Garbom S; Wolf-Watz H
Zoonoses Public Health; 2009 May; 56(4):157-68. PubMed ID: 18793276
[TBL] [Abstract][Full Text] [Related]
30. Nonenzymatic test system for noninstrumental determination of antibodies to species-specific fibers of Yersinia pseudotuberculosis on the basis of nanosized carbon particles.
Rayev MB; Timchenko NF; Bochkova MS; Nedashkovskaya EP; Andrukov BG
Dokl Biochem Biophys; 2013; 451():221-4. PubMed ID: 23975407
[No Abstract] [Full Text] [Related]
31. LcrV synthesis is altered by DNA adenine methylase overproduction in Yersinia pseudotuberculosis and is required to confer immunity in vaccinated hosts.
Badie G; Heithoff DM; Mahan MJ
Infect Immun; 2004 Nov; 72(11):6707-10. PubMed ID: 15501808
[TBL] [Abstract][Full Text] [Related]
32. Serological response of sheep to plasmid-encoded proteins of Yersinia species following natural infection with Y. enterocolitica and Y. pseudotuberculosis.
Robins-Browne RM; Bordun AM; Slee KJ
J Med Microbiol; 1993 Oct; 39(4):268-72. PubMed ID: 8411087
[TBL] [Abstract][Full Text] [Related]
33. [The entry portals and routes of Yersinia pseudotuberculosis penetration into the warm-blooded organism].
Timchenko NF; Antonenko FF
Zh Mikrobiol Epidemiol Immunobiol; 1990 Oct; (10):15-9. PubMed ID: 2075758
[TBL] [Abstract][Full Text] [Related]
34. In vivo immunosuppression induced by a virulent strain of Yersinia pseudotuberculosis.
Simonet M; Berche P
Ann Inst Pasteur Microbiol; 1986; 137B(2):207-10. PubMed ID: 3318867
[No Abstract] [Full Text] [Related]
35. [Immunochemical methods for the diagnosis of pseudotuberculosis (a review of the literature)].
Drobkov VI; Darmov IV
Klin Lab Diagn; 1993; (5):3-7. PubMed ID: 7994540
[No Abstract] [Full Text] [Related]
36. The serodiagnosis of human infections with Yersinia enterocolitica and Yersinia pseudotuberculosis.
Chart H; Cheasty T
FEMS Immunol Med Microbiol; 2006 Aug; 47(3):391-7. PubMed ID: 16872375
[TBL] [Abstract][Full Text] [Related]
37. [Selection of antigens for constructing immunoenzyme test systems for pseudotuberculosis].
Sidorova VE; Bagriantsev VN; Shubin FN; Varvashevich TN
Lab Delo; 1987; (5):371-4. PubMed ID: 2441126
[No Abstract] [Full Text] [Related]
38. Susceptibility to Yersinia pseudotuberculosis infection is linked to the pattern of macrophage activation.
Tansini A; de Medeiros BM
Scand J Immunol; 2009 Apr; 69(4):310-8. PubMed ID: 19284495
[TBL] [Abstract][Full Text] [Related]
39. [The pathogenetic importance of Yersinia pseudotuberculosis lipopolysaccharide].
Kuznetsova TA; Besednova NN
Zh Mikrobiol Epidemiol Immunobiol; 1997; (5):37-41. PubMed ID: 9432844
[TBL] [Abstract][Full Text] [Related]
40. Yersinia pseudotuberculosis adhesins regulate tissue-specific colonization and immune cell localization in a mouse model of systemic infection.
Hudson KJ; Bouton AH
Infect Immun; 2006 Nov; 74(11):6487-90. PubMed ID: 16920785
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
